高水平的IN-8血清水平独立地预测慢性心力衰竭的长期全因死亡率
Jan Traub1,2, Michael K Schuhmann3, Ulrich Hofmann1,2
1Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
Frontiers in cardiovascular medicine
|November 10, 2025
概括
高水平的互白素-8 (IL-8) 预测了心力衰竭患者的死亡率. 这种细胞因子可以作为一种关键的生物标志物和治疗点,用于控制慢性HF进展.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 慢性心力衰竭 (HF) 是一种复杂的疾病,患病率和死亡率很高.
- 炎症在HF进展中起着至关重要的作用.
- 肝炎,炎症,认知障碍和死亡率之间的联系需要进一步调查.
研究的目的:
- 检查慢性HF患者中细胞因子/化学因子配置和轻度认知障碍 (MCI) 之间的关联.
- 确定这些特征与长期全因死亡率之间的关系.
- 为了确定潜在的炎症生物标志物用于HF预后.
主要方法:
- 用多重测定测量了145名高风患者的血清细胞因子水平.
- 患者接受了详细的临床和认知评估.
- 生存数据被追踪了10年,使用考克斯和逻辑回归模型进行统计分析.
主要成果:
- 没有任何特定的细胞因子独立地与MCI相关.
- 升高的IN-8 (IL-8) 水平 (>5.3 pg/ml) 与所有原因死亡率的增加显著相关 (HR: 2.30).
- 在调整了临床和人口因素后,IL-8仍然是死亡率的强大,独立的预测指标.
结论:
- 干白素-8 (IL-8) 在心力衰竭病理生理学中起着独特的作用.
- IL-8显示出作为HF管理中的预后生物标志物和治疗点的潜力.
- 需要进一步的研究来验证IL-8在HF中的临床实用性.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
Heart Failure III: Clinical Manifestations
457
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
457
Heart Failure VII: Nursing Interventions
404
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
404
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K


